Literature DB >> 36074248

Landscape and Construction of a Novel N6-methyladenosine-related LncRNAs in Cervical Cancer.

Xin Liu1, Weijie Zhang2, Jun Wan3, Diming Xiao1, Ming Wei4.   

Abstract

Cervical cancer is a crucial clinical problem with high mortality. Despite much research in therapy, the prognosis of patients with cervical cancer is still not ideal. The data on cervical cancer were downloaded from The Cancer Genome Atlas (TCGA) portal. R language was used to screen out the N6-methyladenosine (m6A)-related lncRNAs (long non-coding RNA). A consensus clustering algorithm was performed to identify m6A-related lncRNAs in cervical cancer; 10 m6A-related lncRNAs showing a significant association with survival were filtrated through a gradually univariate Cox regression model, least absolute shrinkage and selection operator (LASSO) algorithm, and multivariate Cox regression preliminarily. Furthermore, we conducted Kaplan-Meier curves, receiver operating curve (ROC) analyses, and proportional hazards model to quantify the underlying character of the m6A-related model in the prevision of cervical cancer patients. Gene set enrichment analysis (GSEA) was used to explore several pathways significantly. Finally, cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT) was applied to estimate the immune cell infiltration in the profiling. In the present study, 10 m6A-related lncRNAs make up our prediction model. This prediction model can do duty for an independent predictive biomolecular element. Subsequently, we then found that the model was still valid in further validation of the training group and the test group. Our signature was correlated with immune cell infiltration and partial signaling pathway. These lncRNAs played a no negligible biomolecular role in contributing to the prognosis of cervical cancer.
© 2022. The Author(s), under exclusive licence to Society for Reproductive Investigation.

Entities:  

Keywords:  Cervical cancer; N6-methyladenosine; Prognosis; The Cancer Genome Atlas; lncRNA

Year:  2022        PMID: 36074248     DOI: 10.1007/s43032-022-01074-y

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  26 in total

Review 1.  RNA epigenetics.

Authors:  Nian Liu; Tao Pan
Journal:  Transl Res       Date:  2014-04-08       Impact factor: 7.012

Review 2.  LncRNAs: key players and novel insights into cervical cancer.

Authors:  Li Peng; Xiaoqing Yuan; Binyuan Jiang; Zaili Tang; Guan-Cheng Li
Journal:  Tumour Biol       Date:  2015-12-29

Review 3.  Long non-coding RNAs and cervical cancer.

Authors:  Hamid Aalijahan; Saeid Ghorbian
Journal:  Exp Mol Pathol       Date:  2018-11-22       Impact factor: 3.362

Review 4.  The role of m6A RNA methylation in cancer.

Authors:  Ting Sun; Ruiyan Wu; Liang Ming
Journal:  Biomed Pharmacother       Date:  2019-02-19       Impact factor: 6.529

5.  ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation.

Authors:  Yuan He; Hao Hu; Yandong Wang; Hao Yuan; Zipeng Lu; Pengfei Wu; Dongfang Liu; Lei Tian; Jie Yin; Kuirong Jiang; Yi Miao
Journal:  Cell Physiol Biochem       Date:  2018-07-20

6.  Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.

Authors:  Gao-Min Liu; Hua-Dong Zeng; Cai-Yun Zhang; Ji-Wei Xu
Journal:  Dig Dis Sci       Date:  2020-04-24       Impact factor: 3.199

7.  Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix.

Authors:  Kathleen P Saavedra; Priscilla M Brebi; Juan Carlos S Roa
Journal:  Clin Epigenetics       Date:  2012-08-31       Impact factor: 6.551

8.  RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.

Authors:  Bingqing Hui; Hao Ji; Yetao Xu; Juan Wang; Zhonghua Ma; Chongguo Zhang; Keming Wang; Yan Zhou
Journal:  Cell Death Dis       Date:  2019-02-27       Impact factor: 8.469

9.  METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.

Authors:  Xiao Yang; Sen Zhang; Changyu He; Pei Xue; Luyang Zhang; Zirui He; Lu Zang; Bo Feng; Jing Sun; Minhua Zheng
Journal:  Mol Cancer       Date:  2020-02-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.